As the preclinical systematic review study found, KXS, most treated for Alzheimer's Disease and Depression, has an effect on antioxidant activity by decreased ROS and MDA levels via increased GSH and SOD levels. This evidence concerns the gene SOD1 and Alzheimer disease.